1 |
SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
|
2 |
LIU W W, LIANG B, LIU H L, et al. Overexpression of non‑SMC condensin Ⅰ complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma[J]. Int J Mol Med, 2017, 40(3): 731-738.
|
3 |
LIU K K, LI Y M, YU B, et al. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells[J]. Can J Physiol Pharmacol, 2018, 96(12): 1246-1254.
|
4 |
GONG C W, AI J Y, FAN Y, et al. NCAPG promotes the proliferation of hepatocellular carcinoma through PI3K/AKT signaling[J]. Onco Targets Ther, 2019, 12: 8537-8552.
|
5 |
OURA K, MORISHITA A, MASAKI T. Molecular and functional roles of microRNAs in the progression of hepatocellular carcinoma-A review[J]. Int J Mol Sci, 2020, 21(21): 8362.
|
6 |
CUI X, JIANG X Y, WEI C S, et al. Astragaloside Ⅳ suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis[J]. Environ Toxicol Pharmacol, 2020, 78: 103397.
|
7 |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
8 |
KULIK L, EL-SERAG H B. Epidemiology and management of hepatocellular carcinoma[J]. Gastroenterology, 2019, 156(2): 477-491.
|
9 |
SCHLABE S, ROCKSTROH J K. Advances in the treatment of HIV/HCV coinfection in adults[J]. Expert Opin Pharmacother, 2018, 19(1): 49-64.
|
10 |
HUO T I, HSU C Y, LIU P H. Magic mirror on the wall: which is the best biomarker for hepatocellular carcinoma?[J]. Hepatology, 2018, 67(6): 2482-2483.
|
11 |
HARTKE J, JOHNSON M, GHABRIL M. The diagnosis and treatment of hepatocellular carcinoma[J]. Semin Diagn Pathol, 2017, 34(2): 153-159.
|
12 |
SUN J Y, YIN T L, ZHANG X Y, et al. Therapeutic advances for patients with intermediate hepatocellular carcinoma[J]. J Cell Physiol, 2019, 234(8): 12116-12121.
|
13 |
YERUKALA SATHIPATI S, HO S Y. Novel miRNA signature for predicting the stage of hepatocellular carcinoma[J].Sci Rep,2020,10(1):14452.
|
14 |
MOHAMED A A, ALI-ELDIN Z A, ELBEDEWY T A,et al. MicroRNAs and clinical implications in hepatocellular carcinoma[J]. World J Hepatol, 2017, 9(23): 1001-1007.
|
15 |
CHEN F, LI X F, FU D S, et al. Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma[J]. Cancer Biomark, 2017, 18(2): 209-214.
|
16 |
HUNG J H, LI C H, YEH C H, et al. microRNA-224 down-regulates glycine N-methyltransferase gene expression in Hepatocellular Carcinoma[J]. Sci Rep, 2018, 8(1): 12284.
|
17 |
JIANG C, HE Z L, HU X H, et al. MiRNA-15a-3p inhibits the metastasis of hepatocellular carcinoma by interacting with HMOX1[J]. Eur Rev Med Pharmacol Sci, 2020, 24(24): 12694-12700.
|
18 |
YU W S, WANG Z G, GUO R P, et al. Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A[J]. Eur Rev Med Pharmacol Sci, 2020, 24(11): 6046-6054.
|
19 |
CHEN X X, XU X N, PAN B, et al. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer[J].Aging (Albany NY),2018,10(11): 3421-3437.
|
20 |
LU W, ZHANG H H, NIU Y Q, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p[J]. Mol Cancer, 2017, 16(1): 118.
|
21 |
JIANG L L, REN L L, CHEN H, et al. NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer[J]. Cell Death Dis, 2020, 11(7): 547.
|
22 |
WU Y, LIN Y, PAN J F, et al. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway[J]. Cancer Cell Int,2021,21(1): 443.
|
23 |
WANG Y, GAO B, TAN P Y, et al. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth[J]. FASEB J, 2019, 33(8): 8759-8770.
|
24 |
GUO Z Y, ZHU Z T. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2021, 25(23): 7238-7251.
|
25 |
AI J Y, GONG C W, WU J J, et al. microRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG[J]. Cancer Manag Res, 2019, 11: 3455-3467.
|